A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

A new facility opened in Wallingford Saturday afternoon that treats mental health conditions with low doses of Ketamine.

Heaps of ketamine, MDMA and illegal weed were seized by authorities as they busted a drug lab in Queens and arrested the ...

A Colne man who lost his football scholarship in America due to a ketamine addiction is warning people about the dangers of ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...

The FDA approved Johnson & Johnson's Spravato, a ketamine-based nasal spray, to treat adults with major depressive disorder ...

Jeni Larmour died after taking ketamine on her first night at Newcastle University back in September 2020. Sandra Larmour, ...